この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2010/5/51 分で読めます
Withdrawal of Approval of New Animal Drug Applications; Coumaphos; Novobiocin; Buquinolate and Lincomycin
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of three new animal drug applications (NADAs). In a final rule published elsewhere in this issue of the Federal Register, FDA is amending the animal drug regulations to remove portions reflecting approval of the single NADA of the three that is codified.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →